236406-15-8 Usage
General Description
4-Benzyloxycarbonylamino-4-methyl-piperidine is a chemical compound with the molecular formula C17H24N2O2. It is a piperidine derivative with a benzyl and carbonylamino group attached to the nitrogen atom. This chemical is used in organic synthesis as an intermediate or building block in the preparation of pharmaceutical compounds and other organic molecules. It has potential applications in the synthesis of drugs, agrochemicals, and other fine chemicals. The structure and properties of 4-Benzyloxycarbonylamino-4-methyl-piperidine make it suitable for use in various chemical reactions and as a key component in the development of new compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 236406-15-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,6,4,0 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 236406-15:
(8*2)+(7*3)+(6*6)+(5*4)+(4*0)+(3*6)+(2*1)+(1*5)=118
118 % 10 = 8
So 236406-15-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O2/c1-14(7-9-15-10-8-14)16-13(17)18-11-12-5-3-2-4-6-12/h2-6,15H,7-11H2,1H3,(H,16,17)
236406-15-8Relevant articles and documents
Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
-
, (2020/07/21)
The present invention relates to methods for treating Neisseria Gonorrhoeae infection which comprises administering to a subject in need thereof novel 1,2-dihydro-2a,5,8a-triazaacenaphthylene-3,8-dione compounds: or pharmaceutically acceptable salts thereof and/or corresponding pharmaceutical compositions.
COMPOUNDS AND METHODS
-
, (2013/03/26)
The present invention relates to novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
-
, (2008/12/04)
Compounds of Formula (I) in which A, B, R1, R1a, R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class 3 and class 5 receptor tyrosine kinases. Particular compounds of this invention have also been found to be inhibitors of Pim-1